Literature DB >> 31701589

Local impedance guides catheter ablation in patients with ventricular tachycardia.

Paula Münkler1,2, Melanie A Gunawardene1,3, Christiane Jungen1,2, Niklas Klatt1,2, Jana M Schwarzl1, Ruken Ö Akbulak1, Leon Dinshaw1, Jens Hartmann1,3, Mario Jularic1,3, Ann-Kathrin Kahle1, René Riedel4, Lydia Merbold5, Christian Eickholt1,3,2, Stephan Willems1,3,2, Christian Meyer1,2.   

Abstract

AIMS: Catheter contact and local tissue characteristics are relevant information for successful radiofrequency current (RFC)-ablation. Local impedance (LI) has been shown to reflect tissue characteristics and lesion formation during RFC-ablation. Using a novel ablation catheter incorporating three mini-electrodes, we investigated LI in relation to generator impedance (GI) in patients with ventricular tachycardia (VT) and its applicability as an indicator of effective RFC-ablation. METHODS AND
RESULTS: Baseline impedance, Δimpedance during ablation and drop rate (Δimpedance/time) were analyzed for 625 RFC-applications in 28 patients with recurrent VT undergoing RFC-ablation. LI was lower in scarred (87.0 Ω [79.0-95.0]) compared to healthy myocardium (97.5 Ω ([82.75-111.50]; P = .03) while GI did not differ between scarred and healthy myocardium. ΔLI was higher (18 Ω [9.4-26.0]) for VT-terminating as compared to non-terminating RFC-ablation (ΔLI 13 Ω [8.85-18.0]; P = .03), but did not differ for ΔGI between terminating vs nonterminating RFC-ablation. Correspondingly, LI drop rate was higher for RFC-ablation terminating the VT compared with RFC-ablation not terminating the VT (0.63 Ω/s [0.52-0.76] vs 0.32 Ω [0.20-0.58]; P = .008) while there was no difference for GI drop rate. ΔLI was higher in patients with nonischemic cardiomyopathy vs patients with ischemic cardiomyopathy (16 Ω [11.0-20.0] vs 11.0 Ω [7.85-17.00]; P = .003).
CONCLUSION: Our findings suggest that LI is a sensitive parameter to guide RFC-ablation in patients with VT. LI indicates differences in tissue characteristics and generally is higher in patients with nonischemic cardiomyopathy. Hence, the etiology of the underlying cardiomyopathy needs to be considered when adopting LI for monitoring catheter ablation of VT.
© 2019 The Authors. Journal of Cardiovascular Electrophysiology published by Wiley Periodicals, Inc.

Entities:  

Keywords:  catheter ablation; electrical impedance; high-density mapping; radiofrequency; ventricular tachycardia

Year:  2019        PMID: 31701589     DOI: 10.1111/jce.14269

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  5 in total

1.  Local impedance-guided ablation and ultra-high density mapping versus conventional or contact force-guided ablation with mapping for treatment of cavotricuspid isthmus dependent atrial flutter.

Authors:  Karan Saraf; Nicholas Black; Clifford J Garratt; Sahrkaw A Muhyaldeen; Gwilym M Morris
Journal:  Indian Pacing Electrophysiol J       Date:  2022-04-12

2.  Optimal local impedance drops for an effective radiofrequency ablation during cavo-tricuspid isthmus ablation.

Authors:  Takehito Sasaki; Kohki Nakamura; Mitsuho Inoue; Kentaro Minami; Yuko Miki; Koji Goto; Yutaka Take; Kenichi Kaseno; Eiji Yamashita; Keiko Koyama; Shigeto Naito
Journal:  J Arrhythm       Date:  2020-07-16

Review 3.  The challenge of optimising ablation lesions in catheter ablation of ventricular tachycardia.

Authors:  Riccardo Proietti; Luca Lichelli; Nicolas Lellouche; Tarvinder Dhanjal
Journal:  J Arrhythm       Date:  2020-12-28

4.  How to leverage local impedance to guide effective ablation strategy: A case series.

Authors:  Francesco Solimene; Francesco Maddaluno; Maurizio Malacrida; Giuseppe Stabile
Journal:  HeartRhythm Case Rep       Date:  2020-11-07

5.  Local impedance measurements during contact force-guided cavotricuspid isthmus ablation for predicting an effective radiofrequency ablation.

Authors:  Takehito Sasaki; Kohki Nakamura; Kentaro Minami; Yutaka Take; Yosuke Nakatani; Yuko Miki; Koji Goto; Kenichi Kaseno; Eiji Yamashita; Keiko Koyama; Shigeto Naito
Journal:  J Arrhythm       Date:  2022-02-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.